IL52547A - N-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoylbenzamide its optical isomers its n-oxide and pharmaceutically acceptable salts thereof their preparation and pharmaceutical compoistions containing them - Google Patents

N-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoylbenzamide its optical isomers its n-oxide and pharmaceutically acceptable salts thereof their preparation and pharmaceutical compoistions containing them

Info

Publication number
IL52547A
IL52547A IL52547A IL5254777A IL52547A IL 52547 A IL52547 A IL 52547A IL 52547 A IL52547 A IL 52547A IL 5254777 A IL5254777 A IL 5254777A IL 52547 A IL52547 A IL 52547A
Authority
IL
Israel
Prior art keywords
sulphamoylbenzamide
compoistions
pyrrolidylmethyl
dimethoxy
allyl
Prior art date
Application number
IL52547A
Other languages
English (en)
Other versions
IL52547A0 (en
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of IL52547A0 publication Critical patent/IL52547A0/xx
Publication of IL52547A publication Critical patent/IL52547A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL52547A 1976-07-19 1977-07-18 N-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoylbenzamide its optical isomers its n-oxide and pharmaceutically acceptable salts thereof their preparation and pharmaceutical compoistions containing them IL52547A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7622180A FR2358892A1 (fr) 1976-07-19 1976-07-19 N(1'-allyl 2'-pyrrolidylmethyl)2,3-dimethoxy 5-sulfamoyl benzamide, ses derives

Publications (2)

Publication Number Publication Date
IL52547A0 IL52547A0 (en) 1977-10-31
IL52547A true IL52547A (en) 1980-01-31

Family

ID=9175947

Family Applications (1)

Application Number Title Priority Date Filing Date
IL52547A IL52547A (en) 1976-07-19 1977-07-18 N-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoylbenzamide its optical isomers its n-oxide and pharmaceutically acceptable salts thereof their preparation and pharmaceutical compoistions containing them

Country Status (38)

Country Link
US (1) US4499019A (de)
JP (1) JPS5338631A (de)
AR (1) AR214330A1 (de)
AT (1) AT365570B (de)
AU (1) AU509291B2 (de)
BE (1) BE856289A (de)
CH (1) CH627162A5 (de)
CS (1) CS219885B2 (de)
CY (1) CY1036A (de)
DD (2) DD137670A5 (de)
DK (1) DK156646C (de)
EG (1) EG12911A (de)
ES (1) ES460621A1 (de)
FI (1) FI67213C (de)
FR (1) FR2358892A1 (de)
GB (1) GB1539319A (de)
GR (1) GR60836B (de)
HK (1) HK17880A (de)
HU (1) HU174981B (de)
IE (1) IE46171B1 (de)
IL (1) IL52547A (de)
IN (1) IN146993B (de)
LU (1) LU77782A1 (de)
MC (1) MC1153A1 (de)
MX (1) MX4711E (de)
NL (1) NL174347C (de)
NO (1) NO146598C (de)
NZ (1) NZ184634A (de)
OA (1) OA05704A (de)
PH (1) PH12838A (de)
PL (1) PL104244B1 (de)
PT (1) PT66819B (de)
RO (1) RO71691A (de)
SE (1) SE425243B (de)
SU (1) SU695556A3 (de)
YU (1) YU40677B (de)
ZA (1) ZA774256B (de)
ZM (1) ZM5477A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2438650A1 (fr) * 1978-10-11 1980-05-09 Ile De France N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, leurs methodes de preparation et leur application dans le traitement des troubles du bas appareil urinaire
JPS5639431A (en) * 1979-09-06 1981-04-15 Susumu Yagyu Colorimeter having two-light pass length and two-wave length
FR2478093A1 (fr) * 1980-03-12 1981-09-18 Ile De France Nouveau procede de preparation de n-(1-alkyl (ou allyl) 2-pyrrolidinyl-methyl)2-methoxy (ou 2,3-dimethoxy) 5-sulfamoyl (ou sulfamoyl substitue)
FR2550447B1 (fr) * 1983-08-10 1986-01-17 Ile De France Application du n-(ally-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide comme antiagregant plaquettaire
FR2584605B1 (fr) * 1985-07-15 1988-06-17 Ile De France Application du n-(1-allyl-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide dans le traitement de la maladie de parkinson
US7645750B2 (en) * 2006-12-13 2010-01-12 Yung Shin Pharmaceutical Ind. Co., Ltd. Method of treating symptoms of hormonal variations
US8420624B2 (en) * 2007-12-04 2013-04-16 Yung Shin Pharm. Ind. Co., Ltd. Methods for treating or preventing symptoms of hormonal variations
CN105481733A (zh) * 2015-12-30 2016-04-13 苏州诚和医药化学有限公司 一种一步法合成2-甲氧基-5-氨磺酰基苯甲酸甲酯的方法

Also Published As

Publication number Publication date
AU509291B2 (en) 1980-05-01
CH627162A5 (de) 1981-12-31
CY1036A (en) 1980-08-01
DD132492A5 (de) 1978-10-04
PH12838A (en) 1979-09-05
FI67213C (fi) 1985-02-11
FI67213B (fi) 1984-10-31
DD137670A5 (de) 1979-09-19
RO71691A (ro) 1982-09-09
NO146598C (no) 1982-11-03
IE46171B1 (en) 1983-03-23
AU2702677A (en) 1979-01-18
SE7708176L (sv) 1978-01-20
ES460621A1 (es) 1978-05-01
DK156646C (da) 1990-02-05
FR2358892A1 (fr) 1978-02-17
NL174347C (nl) 1984-06-01
FI772214A (de) 1978-01-20
SE425243B (sv) 1982-09-13
PL199723A1 (pl) 1978-04-24
PL104244B1 (pl) 1979-08-31
ATA511677A (de) 1981-06-15
PT66819B (fr) 1978-12-22
ZM5477A1 (en) 1978-05-22
ZA774256B (en) 1978-06-28
AR214330A1 (es) 1979-05-31
IL52547A0 (en) 1977-10-31
US4499019A (en) 1985-02-12
AT365570B (de) 1982-01-25
OA05704A (fr) 1981-05-31
NL174347B (nl) 1984-01-02
NO772530L (no) 1978-01-20
YU40677B (en) 1986-04-30
JPS554724B2 (de) 1980-01-31
NO146598B (no) 1982-07-26
MC1153A1 (fr) 1978-04-17
JPS5338631A (en) 1978-04-08
NZ184634A (en) 1978-11-13
SU695556A3 (ru) 1979-10-30
IE46171L (en) 1978-01-19
HK17880A (en) 1980-04-11
CS219885B2 (en) 1983-03-25
IN146993B (de) 1979-10-20
NL7707982A (nl) 1978-01-23
DK326377A (da) 1978-01-20
BE856289A (fr) 1977-12-30
GB1539319A (en) 1979-01-31
EG12911A (en) 1980-12-31
MX4711E (es) 1982-08-11
DK156646B (da) 1989-09-18
GR60836B (en) 1978-08-31
HU174981B (hu) 1980-04-28
LU77782A1 (de) 1977-10-17
PT66819A (fr) 1977-08-01
YU173977A (en) 1983-01-21
FR2358892B1 (de) 1978-12-15

Similar Documents

Publication Publication Date Title
DE3071186D1 (en) Optically active 1,4-dihydropyridines, processes for their preparation and their use as medicaments
JPS5655315A (en) Novel therapeutic drug using lhhrh or agonist
ES510348A0 (es) "procedimiento de preparacion de nuevos derivados 3,4-dihidro-5h-2,3-benzodiazepinos y de sus sales de adicion acidas farmaceuticamente aceptables".
DE2862445D1 (en) Hydantoin derivatives and salts thereof, their synthesis and pharmaceutical formulations
DE2961804D1 (en) N-(3-benzoylpropyl)-spiro-(dihydrobenzofuranpiperidines and -pyrrolidines), derivatives thereof, methods for their preparation and their use for medicines
IL56248A (en) 4-spectinomycylamine and salts thereof,their preparation and pharmaceutical compositions containing them
IL51309A0 (en) New 1,2-benzisothiazolin-3-ones,their preparation and pharmaceutical compositions containing them
IL52547A (en) N-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoylbenzamide its optical isomers its n-oxide and pharmaceutically acceptable salts thereof their preparation and pharmaceutical compoistions containing them
IT8048968A0 (it) Composti 2,4-diamminopirido (2,3-d)pirimidinici dotati di attivita'farmacologica e procedimento per laloro preparazione
IL53171A (en) Substituted n-(carbamoylalkyl-carbamoylalkyl)-lactam derivatives,their preparation and pharmaceutical compositions containing them
DE2862059D1 (en) Thiazolidinedione-2,4 derivatives, their preparation and pharmaceutical applications
GB1538705A (en) 1,4-dihydropyridine-sugar derivatives process for their preparation and their use as medicaments
SE7800512L (sv) Argininamider och farmaceutiskt godtagbara salter derav
FR2351098A1 (fr) Derives de l'isothiouree, leur procede de preparation et leur application therapeutique
YU197782A (en) Process for obtaining new pyrido(1,2-a0pyrimidine derivatives, and optically active and physiologically tolerated salts thereof
IL52270A (en) 3-(n-(2'-hydroxy-n-propyl)amino)-6-acylhydrazinopyridazinederivatives,their preparation and pharmaceutical compositions containing them
IT1099797B (it) 1. 4-idro-firidazine 1-n-sostituite, procedimento per la loro preparazione e loro impiego come prodoiti medicinali
IL65162A (en) N-(2-dimethylaminomethylfuran-2-ylmethylthio)ethyl)-3-pyridine-carboxamide n-oxide and its salts,their preparation and pharmaceutical compositions containing them
SE7713243L (sv) Substituerade aminoetanoler, deras framstellning och farmaceutiska anvendning
BE886361A (fr) Derives benzylideniques, leur preparation et leur application en therapeutique
IL78801A (en) N2-naphthalene-sulfonyl-l-argininamides,the pharmaceutically acceptable salts thereof,their preparation and pharmaceutical compositions containing them
FR2317923A1 (fr) Derives de 1,3-dihydro-3-phenyl-1'-(2-propynyl) spiro (isobenzofuranes cycloazalcanes), leur procede de preparation et leur application
IL78799A (en) N2-naphthalenesulfonlyl-l-argininamides,the pharmaceutically acceptable salts thereof and pharmaceutical compositions containing them
RO77521A2 (ro) Medicament antireumatic
ZA777605B (en) N-substituted alpha-amido-camphoric acids,their physiologically compatible salts and drugs containing them